Recruiting NA INTERVENTIONAL 3-arm NCT06028503

ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community

Effectiveness of a Community-Based Intervention of Acceptance and Commitment Therapy for Type 2 Diabetes Management in a Rural and Underserved Community

Sponsor: Chelsea Ratcliff, Ph.D.

Conditions Type 2 Diabetes

Interventions Abbott FreeStyle® Libre® 3 Acceptance and Commitment Therapy Generic Education

Updated 7 times since 2023 Last updated: May 12, 2025 Started: Apr 1, 2024 Primary completion: Aug 31, 2026 Completion: Aug 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Type 2 Diabetes and is currently actively recruiting participants. Chelsea Ratcliff, Ph.D. leads this study, which shows 7 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jun 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Jun 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Mar 2024 — May 2024 [monthly]

Not Yet Recruiting NA

▶ Show 2 earlier versions

Nov 2023 — Mar 2024 [monthly]

Not Yet Recruiting NA
Oct 2023 — Nov 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chelsea Ratcliff, Ph.D.
Michael Griffin, Ph.D.
Oluwaseun Olaiya, DO
Owen Kelly, Ph.D.,RNutr
Sam Houston State University

Data source: Sam Houston State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Conroe, United States